Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE, LIPÍDEOS, DOENÇAS CARDIOVASCULARES
ABNT
SHIOZAKI, Afonso Akio et al. Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles. Clinics, v. 71, n. 8, p. 435-439, 2016Tradução . . Disponível em: https://doi.org/10.6061/clinics/2016(08)05. Acesso em: 04 set. 2024.APA
Shiozaki, A. A., Senra, T., Morikawa, A. T., Deus, D. F., Paladino Filho, A. T., Pinto, I. M. F., & Maranhão, R. C. (2016). Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles. Clinics, 71( 8), 435-439. doi:10.6061/clinics/2016(08)05NLM
Shiozaki AA, Senra T, Morikawa AT, Deus DF, Paladino Filho AT, Pinto IMF, Maranhão RC. Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles [Internet]. Clinics. 2016 ; 71( 8): 435-439.[citado 2024 set. 04 ] Available from: https://doi.org/10.6061/clinics/2016(08)05Vancouver
Shiozaki AA, Senra T, Morikawa AT, Deus DF, Paladino Filho AT, Pinto IMF, Maranhão RC. Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles [Internet]. Clinics. 2016 ; 71( 8): 435-439.[citado 2024 set. 04 ] Available from: https://doi.org/10.6061/clinics/2016(08)05